AJ

Alix Joseph

Global Sales & Marketing Director at Linxens Healthcare | BA Investor and Advisor for Medtech start-ups

Lyon, Auvergne-Rhône-Alpes

Invests in

Stages:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

2022

  • Global Sales & Marketing Director

    2023

    Builds and leads the global sales and marketing organization for the Healthcare Business Unit. - Set and ensure business objectives are met. - Provide the team with the tools needed to succeed. - Drive Downstream and Field Marketing activities - Media spokesperson for Linxens Healthcare

  • Vice-President Healthcare (acting)

    2023 - 2024

    • In charge to build Linxens Healthcare organization; • Cover Sales, Marketing, Business Development, Project Management, R&D and Process Engineering; • Set the strategy for the Business Unit; • Integration of Nile AB organization into Linxens organization; • Ensure to meet KPIs for Linxens Healthcare: P&L, Projects, Industrial setup.

  • New Ventures HealthCare Director

    2022 - 2023

  • Seed investor | Business Angel

    2022

    Focusing on Medtech/Health start-ups.

  • Senior Manager Business Development Global Health

    2021 - 2022

    In charge to develop relationship and partnerships with Global Health organizations such as WHO, UNICEF, FIND, UNITAID, ... in order to support the development of diagnostic tools for infectious disease in low resource countries. We drive collaborations between those organization and laboratories using diagnostic solutions in order to resolve technical, technological, educational and logistic challenges. We define and align product and communication strategies toward solutions such as Point-of-Care, rt-PCR and NGS.

2007 - 2021

  • Global Business Unit Director

    2018 - 2021

    I was responsible for establishing the strategy and defining the roadmap to achieve development and sales objectives. Firmly anchored in the activity of laboratory instruments in biochemistry, I have initiated a reorientation of the Business Unit in order to broaden horizons by developing Point-of-Care systems as well as molecular tests. This was driven by close collaboration with Key opinion leaders in obstetrics and gynecology around the world, as well as collaborative programs with the pharmaceutical industries and market access programs with organizations affiliated with WHO and other NGOs (Gates, CHAI, PATH, UNITAIDS,…). This has resulted in particular in a 3-year collaboration with the FIGO (International Federation of Obstetric & Gynecology) with the aim of establishing international guidelines for the management of pre-eclampsia, as well as an extended collaboration with the American Society of Hematology with the aim of develop newborn screening for sickle cell disease in Africa.

  • Market Development Manager EMEA

    2016 - 2018

    Through this role I had the opportunity to propose and lead commercial growth strategies via the development of new distribution networks in Africa, the realization of commercial collaboration (e.g. Mobidiag Oy) as well as to identify targets for strategic investments for the company (e.g. Nightingale).

  • Segment Leader chemagen

    2015 - 2016

    Through this role held in parallel with the position of Sales Director, my mission was to coordinate sales and marketing activities in Europe in order to ensure consistency with sales strategies, and to provide sales teams with visibility on competitors activities in the sector.

  • Sales Director Diagnostics France, French Speaking Africa and South Africa

    2013 - 2016

    This role with P&L control consisted of managing the sales forces, support engineers and service engineers for Diagnostics customers in France and South Africa. I was thus able to lead and supervise teams, set up sales and support structures in Africa as well as develop a distribution network over a large part of the African continent. Also in charge of maintaining relationships with opinion leaders in order to maintain a leading position in our key markets (prenatal and newborn screening), and also to allow the emergence of new high growth segments in molecular testing.

  • Sales & Support Manager Molecular Diagnostics EMEA

    2011 - 2013

    I was invited through this role to create and lead the first EMEA sales and support structure within PerkinElmer with the aim of supporting the development of the company in this new high growth sector. Beyond recruiting, training and supporting new teams, this also required integrating acquisitions (e.g. chemagen), developing the PerkinElmer brand in a new sector and define commercial launch strategies for many new products (Fragile-X, microarrays, DNA/RNA extraction).

  • Sales Specialist Molecular Diagnostics Europe

    2008 - 2011

    • Responsible for Molecular Diagnostics products sales and development in a large region: France, Spain, Italy (since 2010), Portugal and North Africa. • Define with local teams the strategy to introduce new products into every single country in my region. • Provide technical knowledge, support and training in France, Spain, Portugal, Italy, United Kingdom and North Africa. • Manage and organize marketing activities has congress and workshop. • Help to develop and improve current product (develop new protocols) • First region in Europe in terms of sales in Molecular Diagnostics product in 2009. • First region in Europe having sales in the new BACs-on-Beads platform. • Provide sales and marketing trainings to local sales team on Molecular Diagnostics product line.

  • Sales Specialist Molecular Diagnostics France

    2008 - 2008

    • Responsible in Molecular Diagnostics development in France. • Responsible for technical training and support on Molecular Diagnostics products. • Mange organization of marketing events in France for Molecular Diagnostics.

  • Account Manager Genetic Screening France North

    2007 - 2008

    • Responsible for sales of all Genetic Screening products for North of France. • Introduce Molecular Diagnostics products to the French market • Provide high technical level trainings on DELFIA Xpress instrument for Prenatal screening